Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37876 - 37900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	MUC4	4585	upregulated	entinostat results in increased expression of MUC4 mRNA	3q29	A21037
Entinostat	Investigational	MUSTN1	389125	downregulated	entinostat results in decreased expression of MUSTN1 mRNA	3p21.1	A21035
Entinostat	Investigational	MVB12A	93343	upregulated	entinostat results in increased expression of MVB12A mRNA	19p13.11	A21035
Entinostat	Investigational	MVB12B	89853	downregulated	entinostat results in decreased expression of MVB12B mRNA	9q33.3	A21037
Entinostat	Investigational	MXD1	4084	downregulated	entinostat results in decreased expression of MXD1 mRNA	2p13.3	A21037 A21035
Entinostat	Investigational	MXRA7	439921	downregulated	entinostat results in decreased expression of MXRA7 mRNA	17q25.1	A21037
Entinostat	Investigational	MXRA7	439921	upregulated	entinostat results in increased expression of MXRA7 mRNA	17q25.1	A21035
Entinostat	Investigational	MXRA8	54587	upregulated	entinostat results in increased expression of MXRA8 mRNA	1p36.33	A21035
Entinostat	Investigational	MYB	4602	downregulated	entinostat results in decreased expression of MYB mRNA	6q23.3	A21035
Entinostat	Investigational	MYBPC2	4606	upregulated	entinostat results in increased expression of MYBPC2 mRNA	19q13.33	A21037
Entinostat	Investigational	MYCN	4613	upregulated	entinostat results in increased expression of MYCN mRNA	2p24.3	A21037
Entinostat	Investigational	MYH9	4627	upregulated	entinostat results in increased expression of MYH9 mRNA	22q12.3	A21035
Entinostat	Investigational	MYL10	93408	upregulated	entinostat results in increased expression of MYL10 mRNA	7q22.1	A21037 A21035
Entinostat	Investigational	MYL9	10398	upregulated	entinostat results in increased expression of MYL9 mRNA	20q11.23	A21035
Entinostat	Investigational	MYLIP	29116	upregulated	entinostat results in increased expression of MYLIP mRNA	6p22.3	A21037
Entinostat	Investigational	MYLK	4638	downregulated	entinostat results in decreased expression of MYLK mRNA	3q21.1	A21037
Entinostat	Investigational	MYLK-AS1	100506826	downregulated	entinostat results in decreased expression of MYLK-AS1 mRNA	3q21.1	A21037
Entinostat	Investigational	MYO10	4651	upregulated	entinostat results in increased expression of MYO10 mRNA	5p15.1	A21035
Entinostat	Investigational	MYO1B	4430	downregulated	entinostat results in decreased expression of MYO1B mRNA	2q32.3	A21035
Entinostat	Investigational	MYO1C	4641	upregulated	entinostat results in increased expression of MYO1C mRNA	17p13.3	A21035
Entinostat	Investigational	MYO1D	4642	upregulated	entinostat results in increased expression of MYO1D mRNA	17q11.2	A21037 A21035
Entinostat	Investigational	MYO5B	4645	upregulated	entinostat results in increased expression of MYO5B mRNA	18q	A21035
Entinostat	Investigational	MYOCD	93649	downregulated	entinostat results in decreased expression of MYOCD mRNA	17p12	A21035
Entinostat	Investigational	MYOF	26509	upregulated	entinostat results in increased expression of MYOF mRNA	10q23.33	A21037
Entinostat	Investigational	MYOZ3	91977	upregulated	entinostat results in increased expression of MYOZ3 mRNA	5q33.1	A21037 A21035

Displaying entries 37876 - 37900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability